Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Pertuzumab> ?p ?o. }
Showing items 1 to 66 of
66
with 100 items per page.
- Pertuzumab abstract "Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody marketed by Genentech for the treatment of HER2-positive breast cancer, in combination with trastuzumab and docetaxel. The first of its class in a line of agents called "HER dimerization inhibitors". By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth. Pertuzumab received US FDA approval for the treatment of HER2-positive metastatic breast cancer on June 8, 2012. Pertuzumab was developed at Genentech and is now owned by Roche which acquired Genentech in 2009.".
- Pertuzumab atcPrefix "L01".
- Pertuzumab atcSuffix "XC13".
- Pertuzumab casNumber "380610-27-5".
- Pertuzumab fdaUniiCode "K16AIQ8CTM".
- Pertuzumab thumbnail Pertuzumab-HER2_complex_1S78.png?width=300.
- Pertuzumab wikiPageExternalLink www.perjeta.com.
- Pertuzumab wikiPageID "9003588".
- Pertuzumab wikiPageRevisionID "600803626".
- Pertuzumab atcPrefix "L01".
- Pertuzumab atcSuffix "XC13".
- Pertuzumab casNumber "380610".
- Pertuzumab chembl "2007641".
- Pertuzumab chemspiderid "NA".
- Pertuzumab hasPhotoCollection Pertuzumab.
- Pertuzumab kegg "D05446".
- Pertuzumab legalUs "Rx-only".
- Pertuzumab licenceUs "Pertuzumab".
- Pertuzumab mabType "mab".
- Pertuzumab pregnancyUs "D".
- Pertuzumab routesOfAdministration "Intravenous".
- Pertuzumab source "zu/o".
- Pertuzumab target neu.
- Pertuzumab tradename "Perjeta; Omnitarg".
- Pertuzumab type "mab".
- Pertuzumab unii "K16AIQ8CTM".
- Pertuzumab verifiedfields "changed".
- Pertuzumab verifiedrevid "464199526".
- Pertuzumab watchedfields "changed".
- Pertuzumab subject Category:Monoclonal_antibodies.
- Pertuzumab type Abstraction100002137.
- Pertuzumab type Antibody115027189.
- Pertuzumab type Chemical114806838.
- Pertuzumab type Compound114818238.
- Pertuzumab type Macromolecule114944888.
- Pertuzumab type Material114580897.
- Pertuzumab type Matter100020827.
- Pertuzumab type Molecule114682133.
- Pertuzumab type MonoclonalAntibodies.
- Pertuzumab type MonoclonalAntibody115029781.
- Pertuzumab type OrganicCompound114727670.
- Pertuzumab type Part113809207.
- Pertuzumab type PhysicalEntity100001930.
- Pertuzumab type Protein114728724.
- Pertuzumab type Relation100031921.
- Pertuzumab type Substance100019613.
- Pertuzumab type Thing100002452.
- Pertuzumab type Unit109465459.
- Pertuzumab type Drug.
- Pertuzumab type DrugProduct.
- Pertuzumab type FunctionalSubstance.
- Pertuzumab comment "Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody marketed by Genentech for the treatment of HER2-positive breast cancer, in combination with trastuzumab and docetaxel. The first of its class in a line of agents called "HER dimerization inhibitors". By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth.".
- Pertuzumab label "Pertuzumab".
- Pertuzumab label "Pertuzumab".
- Pertuzumab label "Pertuzumabe".
- Pertuzumab label "帕妥珠单抗".
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumabe.
- Pertuzumab sameAs m.027t1rb.
- Pertuzumab sameAs Q1998021.
- Pertuzumab sameAs Q1998021.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab wasDerivedFrom Pertuzumab?oldid=600803626.
- Pertuzumab depiction Pertuzumab-HER2_complex_1S78.png.
- Pertuzumab isPrimaryTopicOf Pertuzumab.